Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FBR Infinity II Ventures is a venture capital fund established as a partnership between the investment bank FBR (Friedman, Billings, Ramsey) and the Infinity Group. The fund specializes in late-stage investments within the life sciences, medical device, and technology sectors, particularly focusing on companies with Israeli roots and global market potential. It provides growth capital and strategic support to help portfolio companies scale and achieve liquidity through IPOs or acquisitions. Notable investments from the fund's portfolio have included companies in the biotechnology and healthcare IT spaces. The fund leverages the cross-border expertise of its partners to facilitate entry into North American and Asian markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FBR Infinity II Ventures.